| Contribution title | ASP - Angoisse de sexuation pubertaire / Pubertal sexuation anxiety |
|---|---|
| Contribution code | D1.009 |
| Authors | |
| Form of presentation | Poster |
| Topic |
|
| Abstract |
Objectives 1. Define ASP / PSA : Establish a clinical framework for pubertal sexuation anxiety (PSA) to understand and treat adolescent distress related to bodily changes during puberty as an alternative to the gender affirmation model. 2. Evaluate the effectiveness of care models: Highlight the limitations of the gender affirmation model in terms of clinical outcomes for adolescents, particularly for those suffering from distress related to the development of secondary sexual characteristics. 3. Propose a holistic therapeutic approach: Develop a methodology focused on psychotherapeutic support and exploring the adolescent's body- and identity-related feelings to encourage a progressive adaptation to pubertal changes. Methods 1. Comparative analysis of clinical approaches: Comparison between gender affirmation and psychotherapeutic support models, with case studies and feedback from the United Kingdom, Sweden, and Finland 2. Clinical observation: case studies 3. Assessment of the influence of social networks: Analysis of the impact of online information and social networks on self-diagnosis Expected results 1. Identification of PSA as a distinct disorder from gender dysphoria 2. Limiting medicalization 3. Better management of bodily distress Conclusion PSA is a new clinical category that aims to specifically treat distress related to pubertal bodily changes without resorting directly to medicalization. This model encourages psychotherapy-centered care, allowing young people to go through this development phase in an environment of support and exploration. The application of a non-invasive therapeutic model to treat anxiety related to pubertal sexuality could respond more sustainably to the needs of these adolescents while respecting their psychological and physical well-being. |